Table 3.

Pathologic and treatment characteristics of breast cancer in Tanzania, 2007–2009

Variables by level	Total distribution (Total N = 488)		Stage 1 & 2 (Total N = 33, 9.27%)		Stage 3 & 4 (Total N = 323, 90.73%)		Early vs. late stage P-value
	No.	%	No.	%	No.	%
ER/PR Status(65,0,61)
ER−/PR−	31	47.69	–	–	29	47.54	–
ER+/PR+	28	43.08	–	–	28	45.9
ER−/PR+	1	1.54	–	–	0	0
ER+/PR−	5	7.69	–	–	4	6.56
Pathologic Diagnostic Type(459,32,308)
Cyto Only	122	26.58	8	25	84	27.27	0.959b
Histo Only	178	38.78	13	40.63	110	35.71
Both	139	30.28	10	31.25	103	33.44
Neither	20	4.36	1	3.13	11	3.57
Treatment(488,33,327)
Chemo Only	75	15.37	1	3.03	62	19.20	0.090b
Radiotherapy Only	3	0.61	0	0	2	0.62
Surgery Only	38	7.79	4	12.12	19	5.88
Chemo & Radiotherapy	19	3.89	0	0	15	4.64
Chemo & Surgery	243	49.80	23	69.69	154	47.68
Radiotherapy & Surgery	12	2.46	1	3.03	9	2.79
Chemo, Surgery, & Radiotherapy	70	14.34	4	12.12	50	15.48
None Recorded	28	5.74	0	0	12	3.72
Chemotherapy(454,30,311)
Neoadjuvant	116	25.55	3	10	88	28.3	0.130b
Adjuvant	267	58.81	24	80	174	55.95
Sandwich	15	3.30	1	3.33	12	3.86
Type Unknown	9	1.98	0	0	7	2.25
Tamoxifen(324,25,226)
No	118	36.42	2	8	82	36.28	0.003c
Yes	206	63.58	23	92	144	63.72

a = Student’s t-test;

^b= Chi-square test;

^c= Fisher’s exact test.